2,3-Dinor-11Beta-Prostaglandin F2 Alpha, Urine
2,3-Dinor-11β-Prostaglandin F2α (2,3-BPG) is a stable urinary metabolite of prostaglandin F2α (PGF2α), a bioactive lipid derived from arachidonic acid via the cyclooxygenase (COX) pathway. PGF2α is involved in smooth muscle contraction, vascular tone regulation, and inflammatory processes. Because PGF2α has a very short half-life in circulation, its measurement is impractical; instead, quantification of its metabolites such as 2,3-BPG in urine provides a reliable surrogate marker of PGF2α biosynthesis.
Elevated urinary 2,3-BPG reflects increased mast cell activation and prostaglandin release. It is particularly useful in systemic mastocytosis, where clonal mast cell proliferation leads to elevated eicosanoid turnover. Beyond mastocytosis, elevated levels have also been reported in cardiovascular disease, certain cancers, and ocular disorders, although the diagnostic specificity in these conditions is limited.
- As an aid in the diagnosis and monitoring of systemic mastocytosis
- Supportive role in evaluating related disorders such as atherosclerosis, endometrial carcinoma, and glaucoma (limited specificity)
Elevated urinary 2,3-BPG:
- Strongly associated with systemic mastocytosis
- May be seen in hypertension, atherosclerosis, endometrial cancer, and glaucoma
<1802 pg/mg of creatinine
24 hours urine collection, random urine.
Stability
- Ambient: 8 hrs.
- Refrigerated: 7 days
- Frozen: 30 days
- J Biol Chem. 1996 Aug 23;271(34):20617-20. [PMID: 8702808]
- J Cell Physiol. 2013 Jan;228(1):25-9. [PMID: 22585670]
- Br J Pharmacol. 2019 Apr;176(8):1059-1078. [PMID: 29679483]
- FEBS Lett. 1998 May 22;428(1-2):32-6. [PMID: 9645469]
- Med Res Rev. 2007 Jul;27(4):435-68. [PMID: 17191216]